USPTO serial 79191669
YUMAB
Reviewed by CopyMark Law Group
Reg. 5238680Status 739Renewal
- Filing date
- Status date
- Registration date
- Jul 11, 2017
- Examiner
- SHANAHAN, PATRICK
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with YUMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph V. Norvell
Joseph V. Norvell Norvell IP, llcP.O. Box 2461Chicago, IL 60690United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Monoclonal antibodies for quantitative determination of leukocyte subsets other than for medical purposes; chemicals components being biochemicals for producing radio-labelled monoclonal antibodies for industrial or scientific purposes; proteins for detecting antibodies other than for medical purposes; ] monoclonal antibodies for industrial use; monoclonal antibody reagents, other than for medical use; antigens and antibodies being biochemicals for diagnostic use not for medical purposes; immunological antibodies, being biochemicals, other than for medical use; tagged antibodies being biochemicals for scientific use; [ monoclonal antibodies for qualitative determination of leukocyte subsets other than for medical purposes; linkage compounds being biochemicals for scientific purposes for coupling of radioactive compounds to antibodies; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; ] biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; proteins for binding antibodies other than for medical purposes; monoclonal antibodies for scientific use; [ linkage compounds being biochemicals for scientific purposes for coupling antibodies to radio nuclides; monoclonal antibodies for research into haematopoietic systems other than for medical purposes; ] reagents for use in development of monoclonal antibodies other than for medical or veterinary purposes; [ components for producing radio-labelled antibody fragments for industrial or scientific purposes being biochemicals; ] tagged antibodies being biochemicals for laboratory use; reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) other than for medical or veterinary purposes comprised primarily of biochemicals | ACTIVE | — |
| 005 | Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions | ACTIVE | — |
| 042 | Scientific research; technological services being antibody engineering and design; industrial analysis and research services in the nature of laboratory research and new product design services relating to the production of monoclonal antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YUMAB GmbH
- Other trademarks owned by YUMAB GmbH
- Other trademarks owned by YUMAB GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named YUMAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 30, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Feb 8, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 15, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 15, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 4, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 27, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 27, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 17, 2024 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 3, 2024 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Mar 25, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 10, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Feb 18, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 15, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 10, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 20, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 20, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 11, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 11, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 25, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 21, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 5, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 20, 2017 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Mar 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 18, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 16, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 28, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 28, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 27, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |